These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3224164)

  • 1. Pharmacokinetics and bioavailability of methocarbamol in rats.
    Obach R; Pruñonosa J; Menargues A; Nomen M; Vallès J
    Biopharm Drug Dispos; 1988; 9(5):501-11. PubMed ID: 3224164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology and pharmacokinetics of high-dose methocarbamol in horses.
    Muir WW; Sams RA; Ashcraft S
    Equine Vet J Suppl; 1992 Feb; (11):41-4. PubMed ID: 9109959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of methocarbamol and guaifenesin after single intravenous and multiple-dose oral administration of methocarbamol in the horse.
    Rumpler MJ; Colahan P; Sams RA
    J Vet Pharmacol Ther; 2014 Feb; 37(1):25-34. PubMed ID: 23859819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of methocarbamol in the thoroughbred race horse.
    Cunningham FE; Fisher JH; Bevelle C; Cwik MJ; Jensen RC
    J Vet Pharmacol Ther; 1992 Mar; 15(1):96-100. PubMed ID: 1573711
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
    Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic analysis of methocarbamol enantiomers in biological fluids.
    Alessi-Severini S; Coutts RT; Jamali F; Pasutto FM
    J Chromatogr; 1992 Nov; 582(1-2):173-9. PubMed ID: 1491037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats.
    Egorin MJ; Yuan ZM; Sentz DL; Plaisance K; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 43(6):445-53. PubMed ID: 10321503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals.
    Sica DA; Comstock TJ; Davis J; Manning L; Powell R; Melikian A; Wright G
    Eur J Clin Pharmacol; 1990; 39(2):193-4. PubMed ID: 2253675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary pharmacokinetics of a new pyridopyrimidine derivative.
    Pérez MJ; Roch MJ; Ochoa MC
    Arzneimittelforschung; 1991 Jun; 41(6):640-4. PubMed ID: 1930354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and intravenous trichloroethylene pharmacokinetics in the rat.
    D'Souza RW; Bruckner JV; Feldman S
    J Toxicol Environ Health; 1985; 15(5):587-601. PubMed ID: 4046066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics and oral bioavailability studies of columbianetin in rats after oral and intravenous administration.
    Luo Q; Wang CP; Li J; Ma WF; Bai Y; Ma L; Gao XM; Zhang BL; Chang YX
    J Ethnopharmacol; 2013 Oct; 150(1):175-80. PubMed ID: 23994338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and oral bioavailability of carbimide in man.
    Obach R; Torrent J; Colom H; Pruñonosa J; Peraire C; Domenech J
    Biopharm Drug Dispos; 1991; 12(6):425-34. PubMed ID: 1932606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cyanamide in dog and rat.
    Obach R; Colom H; Arso J; Peraire C; Pruñonosa J
    J Pharm Pharmacol; 1989 Sep; 41(9):624-7. PubMed ID: 2573707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zidovudine bioavailability and linear pharmacokinetics in female B6C3F1 mice.
    Trang JM; Prejean JD; James RH; Irwin RD; Goehl TJ; Page JG
    Drug Metab Dispos; 1993; 21(1):189-93. PubMed ID: 8095218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of methocarbamol and phenylbutazone in exercised Thoroughbred horses.
    Knych HK; Stanley SD; Seminoff KN; McKemie DS; Kass PH
    J Vet Pharmacol Ther; 2016 Oct; 39(5):469-77. PubMed ID: 26924025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of oral bioavailability of paracetamol by tolmetin in rat.
    Sabater J; Peraire C; Obach R; Moreno J; Domenech J
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():61-5. PubMed ID: 1820937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral idazoxan bioavailability in rat. Relevance of intestinal and hepatic first-pass effect.
    Vallès J; Pruñonosa J; Menargues A; Nomen M; Obach R
    Drug Metab Dispos; 1989; 17(6):673-6. PubMed ID: 2575506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.